Professional

R&D Center

CRMI Technology Centre at the University of Oxford

21 October, 2015 , the United Kingdom, China Regenerative Medicine International Limited is pleased to announce that, has jointly entered into a memorandum of understanding (“MOU”), being on the State Visit to the United Kingdom by President Xi Jinping of the PRC, to establish the “The CCBI-CRMI Technology Centre at the University of Oxford” with the University of Oxford and CCB International (Holdings) Limited.

This is also one of the cooperation achievements for life sciences realized during the State Visit to the United Kingdom by President Xi.

CRMI is the third enterprise to set up such a research and development technology centre that is sponsored by enterprise and undertaking research at the University of Oxford.

“The CCBI-CRMI Technology Centre at the University of Oxford” is part of the Oxford Institute of Biomedical Engineering (IBME), directed by Professor Zhanfeng Cui, who is the Donald Pollock Professor of Chemical Engineering at Oxford and a Fellow of the Royal Academy of Engineering.

Being an innovative high-tech enterprise, CRMI always takes research and development of technology as the foundation for corporate development. The cooperation with the University of Oxford not only constructs an international R&D network for China Regenerative Medicine International Limited, but also provides training opportunities to scientific researchers in China. Meanwhile, the cooperation is a bridge for scientific exchanges between China and the UK, becoming a new momentum for the development in the course of human life health.

IR Contact

China Regenerative Medicine International Limited

A:

10/F, Dah Sing Financial Center, 108 Gloucester Road, Wan chai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026